International Conference on Malignant Lymphoma - ICML
www.icml.ch The next ICML (17-ICML) will be held from June 13 to June 17, 2023.
The International Conference on Malignant Lymphoma (ICML) is a key event for the scientific community engaged in the study and treatment of lymphoid neoplasms. The ICML is organized by the Foundation for the Institute of Oncology Research (IOR), in cooperation with the American Association for Cancer Research (AACR), and is held in Lugano (Switzerland) every two years bringing together up to 3โ500 physicians and scientists from all over the world.
17/06/2024
๐ขRegistration to the 18-ICML is open!
Don't miss the opportunity to participate in the only international conference that focuses exclusively on lymphoid neoplasms!
๐Register now: shorturl.at/LHtyT
๐ The Abstract and Educational Books, supplements to "Hematological Oncology" (John Wiley and Sons, Inc.), are online!
๐ Abstract Book: https://shorturl.at/qF145
๐ Educational Book: https://t.ly/8NZm
๐ค #17-ICML Late Breaking Abstracts Session
The content of the Late Breaking Abstracts Session (Saturday, June 17, 10:15 - 11:30) is now online!
๐๐ป Discover the presentations here: https://shorturl.at/lvF38
๐๐ป๐๐ฝโโ๏ธAre you planning to participate in the 17-ICML? Join the ยซCorsa della speranza (Run for Hope)ยป, a charity run organized in collaboration with ยซLa Corsa della speranzaยป during the 17-ICML with the aim to collect funds for cancer research projects carried out in Southern Switzerland.
๐ Info and registration: https://bit.ly/41xm7S9
Corsa della speranza Lugano EOC - Ente Ospedaliero Cantonale
๐ค Plenary session
"Nivolumab(N)-AVD Improves Progression-Free Survival Compared to Brentuximab Vedotin(BV)-AVD in Advanced Stage (AS) Classic Hodgkin Lymphoma (HL): Results of SWOG S1826" will be presented by Alex F. Herrera (Duarte, CA, US) and discussed by Peter Borchmann (Cologne, DE).
๐Discover the complete Scientific Program: bit.ly/3IlOc7h
๐ค Plenary session
"Frontline intensified ABVD demonstrates superior efficacy than PET-adapted ABVD in advanced Hodgkin Lymphoma: the FIL-Rouge Phase 3 Trial by the Fondazione Italiana Linfomi" will be presented by Antonio Pinto (Naples, IT) and discussed by Peter Borchmann (Cologne, DE).
Discover the complete Scientific Program: bit.ly/3IlOc7h
๐ข๐ The Scientific Program IS ONLINE!
Many thanks to our Advisory Board and reviewers for the precious help!
Check it out to schedule your attendance and stay informed about the latest data in the field of !
๐ https://icml.ch/icml/program.html
๐ Keynote Memorial Lectures
The 17-ICML Memorial Lecture dedicated to John Ultmann and organized in collaboration with the American Association for Cancer Research (AACR), will be held by Peter Johnson (Southampton, UK), who will summarize "25 years of antibody treatments for ".
Stay tuned for the complete Scientific Program!
๐ Keynote Memorial Lectures
The 17-ICML Gianni Bonadonna Lecture, supported by the European School of Oncology (ESO), will be held by Ralf Kรผppers (Essen, Germany), who will elucidate the enigmatic pathobiology of .
Stay tuned for the Scientific Program!
๐ The Keynote Memorial Lectures, dedicated to Henry Kaplan, Gianni Bonadonna and John Ultmann are among the most significant moments of the ICML.
In the Henry Kaplan Memorial Lecture, linked to the San Salvatore Foundation Prize, Margaret A. Shipp (Boston, MA, USA) will present "Lessons learned from the genetic heterogeneity of lymphoid malignancies".
Stay tuned for the complete Scientific Program!
๐๐ป๐๐ฝโโ๏ธPhysicians and citizens together for cancer research!
Join the Corsa della speranza (Run for Hope) - ICML edition, you will run, march or walk on a 5km route through the most characteristic streets of Lugano!
๐ Info and registration: https://bit.ly/41xm7S9
Corsa della speranza Lugano
26/04/2023
๐ Applications for the European School of Oncology (ESO) ๐ ๐ฎ๐๐๐ฒ๐ฟ๐ฐ๐น๐ฎ๐๐ ๐ถ๐ป ๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ - ๐๐๐๐๐บ๐ป ๐ฒ๐ฑ๐ถ๐๐ถ๐ผ๐ป - ARE OPEN!
This full immersion, clinical oriented Masterclass is a HYBRID EVENT
- Pre-recorded online lectures
- IN-PERSON EVENT in ๐ Varese, Milan area - Italy
๐ณ๐ผ๐ฟ ๐บ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐ฎ๐ป๐ฑ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ผ๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ถ๐๐๐ with 3-4 years experience who would like to receive further training on the treatment of tumours.
๐จAttendance to the Masterclass is BY APPLICATION ONLY.
Successful applicants are granted โก๏ธ๐๐จ๐๐ ๐๐ข๐๐ฅ๐ ๐๐๐๐ข๐ ๐ ๐ข๐๐๐ง๐๐ข๐ก.
๐
Deadline for applications: 9 July 2023.
Further info ๐https://bit.ly/3z3GQjQ
๐ข๐The Scientific Program, based on more than 800 submitted abstracts, is almost ready!
Watch the video to have a sneak peek of the 17-ICML and stay tuned!
20/03/2023
Live from ICML Hdqtrs - The Organizing Committee is at work with the numerous abstracts received๐๐.
๐๐ป Well done to all authors!
๐ And soon it'll be our Advisory Board and evaluation panel's turn to review!
๐ข๐ Just over one week until the call for abstracts closes! Deadline is March 15, 2023, at 17:59 CET. Abstracts can be related to all aspects of the biology and treatment of , including and .
๐ Late-breaking abstracts: covering letters due by March 15 at 17:59 CET.
๐ Find more info here: https://bit.ly/3yimens
๐ Today is the last day to take advantage of the Early registration fee for the !
๐๐ป Register here: https://bit.ly/3IrWLhb
โฐLast days to take advantage of the Early registration fee! Deadline is February 28, 2023.
๐ Register here: https://bit.ly/3IrWLhb
๐ Only one week left to take advantage of the Early registration fee! Deadline is February 28, 2023.
๐ Register here: https://bit.ly/3IrWLhb
โฐ ๐ข๐ Just over one month until the call for abstracts closes! Deadline is March 15 at 17:59 CET.
๐ Late-breaking abstracts: covering letters are also due by March 15 at 17:59 CET.
๐ Find more info here: https://bit.ly/3CZbVaS
๐Only one month left to take advantage of the early registration fee (February 28)!
๐ More information: https://bit.ly/3XJu4Ba
20/01/2023
โCOVID and haematological malignanciesโ is the first webinar of the Cancer & Covid: Prevention and Treatment with Monoclonal Antibodies (MoABs) Educational Project.
The aim of this session is to spread awareness and knowledge among HCPs on vaccination efficacy, COVID outcome, COVID treatment and prophylaxis with moABs in haematological patients.
๐
Join us on the 24th of January 2023, 18:00 CET
๐ Register now at http://ow.ly/QibK50Mgbbq and ask the experts Carsten Bokemeyer, Carsten Utoft Niemann, Anna Sureda.
This activity is supported by an independent educational grant from AstraZeneca.
๐ข๐ The abstract submission for the is officially open!
Abstracts can be related to all aspects of the biology and treatment of , including and .
More info: https://bit.ly/3j8yaEd
13/06/2022
๐ The 17-ICML Organizing Committee is happy to announce that itโs now possible to register for the 17-ICML, which will take place in Lugano from June 13 to 17, 2023.
๐Find all details and check out the Preliminary Program on our website: www.icml.ch
10/02/2022
๐Congratulations to the lymphoma teams of the Institute of Oncology Research (IOR) and the Oncological Institute of Southern Switzerland (IOSI, EOC) for their review on marginal zone lymphoma published in the New England Journal of Medicine.
๐Read the review: https://bit.ly/3LkbpGZ
๐ขRead the news:
English version https://bit.ly/3LlGry7
Italian version https://bit.ly/3su9eb2
IOR e IOSI medaglia d'oro nei linfomi Il New England Journal of Medicine (NEJM), la rivista medica piรน importante al mondo, ha affidato al gruppo linfomi dell'Istituto oncologico di ricerca (IOR, affiliato all'USI e membro di BIOS+) e dell'Istituto Oncologico della Svizzera Italiana (IOSI, Ente Ospedaliero Cantonale) il compito di stil...
23/09/2021
We are delighted to launch our next online webinar โTopics around high-grade lymphomaโ.
The programme covers the following topics:
- ICML and other hot news
- Randomized trials of antiemetic treatment in high-grade lymphoma
- ESMO/MASCC guidelines for prevention of CINV in high-risk hematogenic treatments
The webinar is held under the auspices of International Conference on Malignant Lymphoma - ICML
29 September 2021 โ 18:00 CEST
Faculty
General information
๐Connection link: https://www.oncocorner.net/webinars/235
The webinar is CME accredited and free of charge.
To obtain the certificate, register on the OncoCorner homepage at this link: https://www.oncocorner.net/home
Did you miss the ?
Good news: you can access the Congress materials on-demand and enjoy the 16-ICML anytime you wish until July 11, 2022!
Discover more: www.icml.ch
Klicken Sie hier, um Ihren Gesponserten Eintrag zu erhalten.
Videos (alles anzeigen)
Kategorie
die Praxis kontaktieren
Webseite
Adresse
Bellinzona
Fondazione Sasso Corbaro
Via Lugano 4a, Piazzetta Lucia Buonvicini
Bellinzona, 6500
La Fondazione Sasso Corbaro si dedica alla promozione della formazione, della ricerca, della documentazione e della consulenza nell'ambito delle Medical Humanities e dell'etica cl...
Farmacia Azione
Via Franco Zorzi 36
Bellinzona, 6500
Cerchiamo, con lo studio delle nuove e vecchie medicine, la dispensazione dei farmaci, la ricerca e la produzione di preparati antichi ma efficaci, lโintegrazione con le ultime nov...
Sentieri nelle Medical Humanities
C/o Fondazione Sasso Corbaro, Via Lugano 4A
Bellinzona, 6500
Articoli inerenti alle Medical Humanities e allโetica clinica
IOR Institute of Oncology Research
Via Vela 6
Bellinzona, 6500
A cancer research institute in the sunny south of Switzerland.
Centro Ergoterapia Pediatrica
Via Ghiringhelli 19 A
Bellinzona, 6500
Accoglienza, condivisione e umanitร sono i nostri valori. Il nostro centro offre ergoterapia per bambini, formazione e consulenza.
Atelier Creandi
Viale Officina 8
Bellinzona, 6500
ATELIER DI PITTURA E ARTETERAPIA. SVILUPPA LA TUA CREATIVITร. SCOPRI I VANTAGGI PER GUARDARE LE SITUAZIONI CON UN ALTRA PROSPETTIVA.
Infermieri indipendenti
Bellinzona, 6500
Infermiere a domicilio, indipendenti che prestano la loro opera in cantone Ticino.
Day Hospital indipendenza
Via Lugano 2
Bellinzona, 6500BELLINZONA
Psicologia, psicoterapia, psicoanalisi, psichiatria, sviluppo e potenziamento competenze e potenzialitร mentali/psicologiche/cognitive/sociali. Laboratori creativi, sociali, cognit...